Sort   by:  
 Page size 
UnknownSWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Not available
S-EPMC4534524 | biostudies-literature
TranscriptomicsBY4742 Quiescent and Non-quiescent replicates
Cells in glucose-limited Saccharomyces cerevisiae cultures differentiate into quiescent (Q) and non-quiescent (NQ) fractions prior to entering stationary phase. To identify genes involved in this differentiation, Q and NQ cells from 101 deletion-mutant strains were tested for viability and reproduc...
ORGANISM(S): Saccharomyces cerevisiae 
2010-05-27 | E-GEOD-8542 | biostudies-arrayexpress
TranscriptomicsMutant2
Cells in glucose-limited Saccharomyces cerevisiae cultures differentiate into quiescent (Q) and non-quiescent (NQ) fractions prior to entering stationary phase. To identify genes involved in this differentiation, Q and NQ cells from 101 deletion-mutant strains were tested for viability and reproduc...
ORGANISM(S): Saccharomyces cerevisiae 
2007-12-26 | E-GEOD-8561 | biostudies-arrayexpress
TranscriptomicsS288c Quiescent and Non-quiescent replicates
Cells in glucose-limited Saccharomyces cerevisiae cultures differentiate into quiescent (Q) and non-quiescent (NQ) fractions prior to entering stationary phase. To identify genes involved in this differentiation, Q and NQ cells from 101 deletion-mutant strains were tested for viability and reproduc...
ORGANISM(S): Saccharomyces cerevisiae 
2010-05-27 | E-GEOD-8559 | biostudies-arrayexpress
TranscriptomicsMutant1
Cells in glucose-limited Saccharomyces cerevisiae cultures differentiate into quiescent (Q) and non-quiescent (NQ) fractions prior to entering stationary phase. To identify genes involved in this differentiation, Q and NQ cells from 101 deletion-mutant strains were tested for viability and reproduc...
ORGANISM(S): Saccharomyces cerevisiae 
2007-12-26 | E-GEOD-8560 | biostudies-arrayexpress
UnknownThe Gastrointestinal Pain Pointer: A Valid and Innovative Method to Assess Gastrointestinal Symptoms.
Not available
S-EPMC4902787 | biostudies-literature
GenomicsGlioma GWAS summary statistics
Meta-analysis association statistics from case-control analysis (includes imputed SNPs)
EGAD00010001657 | EGA
GenomicsSummary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.
Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, but individual studies have had limited power to identify risk loci. We performed a meta-analysis of existing GWAS and two new GWAS, which totaled 12,488 cases and 18,169 controls. We identified five ...
EGAS00001003372 | EGA
GenomicsGlioma GWAS summary statistics DAC
Data Access Committee EGAC00001001116
EGAC00001001116 | EGA
Sort   by:  
 Page size